The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis

Ciccarone, 2019, The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis, Int J Drug Policy, 71, 183, 10.1016/j.drugpo.2019.01.010

Ciccarone, 2017, Fentanyl in the US heroin supply: A rapidly changing risk environment, Int J Drug Policy, 46, 107, 10.1016/j.drugpo.2017.06.010

Wilson, 2020, Drug and opioid-involved overdose deaths – United States, 2017–2018, Morb Mortal Wkly Rep, 69, 290, 10.15585/mmwr.mm6911a4

Guy, 2017, Vital signs: changes in opioid prescribing in the United States, 2006–2015, Morb Mortal Wkly Rep, 66, 697, 10.15585/mmwr.mm6626a4

Jalal, 2020, Carfentanil and the rise and fall of overdose deaths in the United States, Addiction

Wakeman, 2020, An overdose surge will compound the COVID-19 pandemic if urgent action is not taken, Nat Med, 26, 819, 10.1038/s41591-020-0898-0

Arena, 2020, Race, COVID-19 and deaths of despair, EClinicalMedicine, 25, 100485, 10.1016/j.eclinm.2020.100485

Koob, 2020, Addiction as a coping response: hyperkatifeia, deaths of despair, and COVID-19, Am J Psychiatry, 177, 1031, 10.1176/appi.ajp.2020.20091375

O’Donnell, 2020, Notes from the field: opioid-involved overdose deaths with fentanyl or fentanyl analogs detected - 28 states and the District of Columbia, July 2016-December 2018, Morb Mortal Wkly Rep, 69, 271, 10.15585/mmwr.mm6910a4

Krotulski, 2021, Brorphine-Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography-mass spectrometry, J Forensic Sci, 66, 664, 10.1111/1556-4029.14623

Rosenblum, 2020, The rapidly changing US illicit drug market and the potential for an improved early warning system: Evidence from ohio drug crime labs, Drug Alcohol Depend, 208, 107779, 10.1016/j.drugalcdep.2019.107779

Pardo, 2020, The dawn of a new synthetic opioid era: the need for innovative interventions, Addiction

Mars, 2019, Illicit fentanyls in the opioid street market: Desired or imposed?, Addiction, 114, 774, 10.1111/add.14474

Ciccarone, 2017, Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’, Int J Drug Policy, 46, 146, 10.1016/j.drugpo.2017.06.004

Mars, 2018, Sold as heroin: Perceptions and use of an evolving drug in Baltimore, MD, J Psychoactive Drugs, 50, 1, 10.1080/02791072.2017.1394508

O’Donnell, 2017, Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by Census Region - United States, 2006–2015, Morb Mortal Wkly Rep, 66, 897, 10.15585/mmwr.mm6634a2

Gladden, 2016, Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 states, 2013–2014, MMWR Morb Mortal Wkly Rep, 65, 837, 10.15585/mmwr.mm6533a2

Unick, 2017, US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations, Int J Drug Policy, 46, 112, 10.1016/j.drugpo.2017.06.003

Carroll, 2017, Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study, Int J Drug Policy, 46, 136, 10.1016/j.drugpo.2017.05.023

Somerville, 2017, Characteristics of fentanyl overdose - Massachusetts, 2014–2016, Morb Mortal Wkly Rep, 66, 382, 10.15585/mmwr.mm6614a2

Rothberg, 2018, Fentanyl: a whole new world?, J Law Med Ethics, 46, 314, 10.1177/1073110518782937

Hempstead, 2014, Supply-side response to declining heroin purity: fentanyl overdose episode in New Jersey, Health Econ, 23, 688, 10.1002/hec.2937

Shover, 2020, Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance, Drug Alcohol Depend, 216, 108314, 10.1016/j.drugalcdep.2020.108314

Pouget, 2018, Racial/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to opioid treatment programs, 2005–2016, Subst Use Misuse, 53, 290, 10.1080/10826084.2017.1334070

Jones, 2015, Vital signs: demographic and substance use trends among heroin users - United States, 2002–2013, Morb Mortal Wkly Rep, 64, 719

Unick, 2013, Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993–2009, PLoS One, 8, e54496, 10.1371/journal.pone.0054496

Lippold, 2019, Racial/ethnic and age group differences in opioid and synthetic opioid- involved overdose deaths among adults aged > / = 18 years in metropolitan areas - United States, 2015–2017, Morb Mortal Wkly Rep, 68, 967, 10.15585/mmwr.mm6843a3

Drake, 2020, Exploring the impact of the opioid epidemic in Black and Hispanic communities in the United States, Drug Sci Policy Law, 6, 2050324520940428, 10.1177/2050324520940428

James, 2018, The opioid crisis in black communities, J Law Med Ethics, 46, 404, 10.1177/1073110518782949

Hansen, 2016, Is the prescription opioid epidemic a white problem?, Am J Public Health, 106, 2127, 10.2105/AJPH.2016.303483

Mazhnaya, 2020, Fentanyl preference among people who inject drugs in West Virginia, Subst Use Misuse, 55, 1774, 10.1080/10826084.2020.1762653

Morales, 2019, Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities, Drug Alcohol Depend, 204, 107547, 10.1016/j.drugalcdep.2019.107547

Park, 2020, Situating the continuum of overdose risk in the social determinants of health: a new conceptual framework, Milbank Q, 98, 700, 10.1111/1468-0009.12470

Kline, 2021, Opioid overdose in the age of fentanyl: risk factor differences among subpopulations of overdose survivors, Int J Drug Policy, 90, 103051, 10.1016/j.drugpo.2020.103051

Dasgupta, 2018, Opioid crisis: No easy fix to its social and economic determinants, Am J Public Health, 108, 182, 10.2105/AJPH.2017.304187

Seal, 2001, Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999, Am J Public Health, 91, 1842, 10.2105/AJPH.91.11.1842

Hunter, 2018, Safe and unsafe spaces: nonfatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City, Int J Drug Policy, 57, 25, 10.1016/j.drugpo.2018.03.026

Case, 2017, Mortality and morbidity in the 21st century, Brookings Pap Econ Act, Spring, 397, 10.1353/eca.2017.0005

Muennig, 2018, America's declining well being, health, and life expectancy: not just a white problem, Am J Public Health, 108, 1626, 10.2105/AJPH.2018.304585

McLean, 2016, There's nothing here’: deindustrialization as risk environment for overdose, Int J Drug Policy, 29, 19, 10.1016/j.drugpo.2016.01.009

Pear, 2019, Urban-rural variation in the socioeconomic determinants of opioid overdose, Drug Alcohol Depend, 195, 66, 10.1016/j.drugalcdep.2018.11.024

Zoorob, 2017, Bowling alone, dying together: the role of social capital in mitigating the drug overdose epidemic in the United States, Drug Alcohol Depend, 173, 1, 10.1016/j.drugalcdep.2016.12.011

Monnat, 2018, Factors associated with county-level differences in US drug-related mortality rates, Am Prevent Med, 54, 611, 10.1016/j.amepre.2018.01.040

Hollingsworth, 2017, Macroeconomic conditions and opioid abuse, J Health Econ, 56, 222, 10.1016/j.jhealeco.2017.07.009

Dean, 2019, Free trade and opioid overdose death in the United States, SSM Population Health, 8, 100409, 10.1016/j.ssmph.2019.100409

Rigg, 2018, Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies, Int J Drug Policy, 57, 119, 10.1016/j.drugpo.2018.04.011

Jalal, 2018, Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016, Science, 361, eaau1184, 10.1126/science.aau1184

Volkow, 2020, Collision of the COVID-19 and addiction epidemics, Ann Intern Med, 173, 61, 10.7326/M20-1212

Suzuki, 2017, A review: fentanyl and nonpharmaceutical fentanyls, Drug Alcohol Depend, 171, 107, 10.1016/j.drugalcdep.2016.11.033

Heyman, 2019, Evidence that social-economic factors play an important role in drug overdose deaths, Int J Drug Policy, 74, 274, 10.1016/j.drugpo.2019.07.026

Monnat, 2019, The contributions of socioeconomic and opioid supply factors to U.S. drug mortality rates: Urban-rural and within-rural differences, J Rural Studies, 68, 319, 10.1016/j.jrurstud.2018.12.004

Han, 2021, Methamphetamine overdose deaths in the US by sex and race and ethnicity, JAMA Psychiatry, 10.1001/jamapsychiatry.2020.4321

Glick, 2018, Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington, Drug Alcohol Depend, 182, 86, 10.1016/j.drugalcdep.2017.10.011

Wakeman, 2021, Rise in presence of methamphetamine in oral fluid toxicology tests among outpatients in a large healthcare setting in the Northeast, J Addict Med, 15, 85, 10.1097/ADM.0000000000000695

Palamar, 2021, Shifts in drug seizures in the United States during the COVID-19 pandemic, Drug Alcohol Depend, 221, 108580, 10.1016/j.drugalcdep.2021.108580

Gladden, 2019, Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine - 25 states, July-December 2017 to January-June 2018, Morb Mortal Wkly Rep, 68, 737, 10.15585/mmwr.mm6834a2

Jones, 2018, Changes in synthetic opioid involvement in drug overdose deaths in the united states, 2010–2016, JAMA, 319, 1819, 10.1001/jama.2018.2844

Al-Tayyib, 2017, Heroin and methamphetamine injection: an emerging drug use pattern, Subst Use Misuse, 52, 1051, 10.1080/10826084.2016.1271432

Mars, 2015, Heroin-related overdose: the unexplored influences of markets, marketing and source-types in the United States, Soc Sci Med, 140, 44, 10.1016/j.socscimed.2015.06.032

Strickland, 2019, A nationally representative analysis of ‘twin epidemics’: rising rates of methamphetamine use among persons who use opioids, Drug Alcohol Depend, 204, 107592, 10.1016/j.drugalcdep.2019.107592

Barocas, 2019, Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths, Drug Alcohol Depend, 200, 59, 10.1016/j.drugalcdep.2019.03.014

Hall, 2008, Estimation of HIV incidence in the United States, JAMA, 300, 520, 10.1001/jama.300.5.520

Lyss, 2020, Responding to outbreaks of human immunodeficiency virus among persons who inject drugs-United States, 2016–2019: Perspectives on Recent Experience and Lessons Learned, J Infect Dis, 222, S239, 10.1093/infdis/jiaa112

Zibbell, 2018, Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014, Am J Public Health, 108, 175, 10.2105/AJPH.2017.304132

Alpren, 2020, Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015–2018, Am J Public Health, 110, 37, 10.2105/AJPH.2019.305366

Shearer, 2020, Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015–2018, Drug Alcohol Depend, 214, 108162, 10.1016/j.drugalcdep.2020.108162

Cai, 2020, Risk factors associated with infection of blood-borne virus among people who used methamphetamine, BMC Infect Dis, 20, 742, 10.1186/s12879-020-05464-y

Ciccarone, 2016, Nationwide increase in hospitalizations for heroin-related soft tissue infections: associations with structural market conditions, Drug Alcohol Depend, 163, 126, 10.1016/j.drugalcdep.2016.04.009

See, 2020, National public health burden estimates of endocarditis and skin and soft-tissue infections related to injection drug use: a review, J Infect Dis, 222, S429, 10.1093/infdis/jiaa149

Ciccarone, 2011, Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy, Prim Care, 38, 41, 10.1016/j.pop.2010.11.004

Saloner, 2018, A public health strategy for the opioid crisis, Public Health Rep, 133, 24S, 10.1177/0033354918793627

Strang, 2020, Opioid use disorder, Nat Rev Dis Primers, 6, 3, 10.1038/s41572-019-0137-5

Trivedi, 2021, Bupropion and naltrexone in methamphetamine use disorder, N Engl J Med, 384, 140, 10.1056/NEJMoa2020214

Coffin, 2020, Effects of mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: a placebo-controlled randomized clinical trial, JAMA Psychiatry, 77, 246, 10.1001/jamapsychiatry.2019.3655

Strang, 2012, Drug policy and the public good: evidence for effective interventions, Lancet, 379, 71, 10.1016/S0140-6736(11)61674-7

Cottler, 2020, Introducing NIDA's New National Drug Early Warning System, Drug Alcohol Depend, 217, 108286, 10.1016/j.drugalcdep.2020.108286

Macias-Konstantopoulos, 2021, Between emergency department visits: the role of harm reduction programs in mitigating the harms associated with injection drug use, Ann Emerg Med, 77, 479, 10.1016/j.annemergmed.2020.11.008

Hayes, 2021, Harm reduction, by mail: the next step in promoting the health of people who use drugs, J Urban Health, 10.1007/s11524-021-00534-1

Peiper, 2019, Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States, Int J Drug Policy, 63, 122, 10.1016/j.drugpo.2018.08.007

Zibbell, 2021, Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina, Int J Drug Policy, 10.1016/j.drugpo.2021.103128

Park, 2021, Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs, Int J Drug Policy, 94, 103196, 10.1016/j.drugpo.2021.103196

Palamar, 2020, Drug checking to detect fentanyl and new psychoactive substances, Curr Opin Psychiatry, 33, 301, 10.1097/YCO.0000000000000607

Servis, 2021, Responding to the opioid epidemic: educational competencies for pain and substance use disorder from the Medical Schools of the University of California, Pain Med, 22, 60, 10.1093/pm/pnaa399

Jordan, 2020, Building outreach and diversity in the field of addictions, Am J Addict, 29, 413, 10.1111/ajad.13097

Parker, 2019, Facing Opioids in the Shadow of the HIV Epidemic, N Engl J Med, 380, 1, 10.1056/NEJMp1813836